Related Experiment Video
Updated: Jul 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study.
Luigina Guasti1, Franca Marino, Marco Cosentino
1Department of Clinical Medicine, University of Insubria, Varese, Italy. luigina.guasti@uninsubria.it
Statin treatment reduces pro-inflammatory properties in neutrophils of high-risk individuals. This involves decreased interleukin-8 (IL-8) production and chemotaxis, impacting neutrophil activation.
Area of Science:
- Cardiovascular Research
- Immunology
- Pharmacology
Background:
- Polymorphonuclear leukocytes (PMNs) play a key role in atherosclerosis.
- Limited data exist on PMN function and pharmacological modulation in high-risk individuals.
Purpose of the Study:
- Investigate interleukin-8 (IL-8) production, migration, chemotaxis, and reactive oxygen species (ROS) generation in PMNs from high-risk individuals during simvastatin treatment.
- Compare PMN function between high-risk patients and healthy controls.
Main Methods:
- Longitudinal study of 21 high-risk individuals undergoing simvastatin treatment.
- PMN isolation before, and 3 and 30 days after treatment initiation.
- Comparison with PMNs from healthy controls.
Main Results:
- Simvastatin treatment significantly reduced IL-8 production (resting and stimulated) and chemotactic index.
- Reactive oxygen species (ROS) generation did not change significantly.
- High-risk patients exhibited higher baseline IL-8 production and ROS generation compared to controls.
Conclusions:
- Neutrophils in high-risk individuals show activation, evidenced by enhanced IL-8 production and ROS generation.
- Four-week statin treatment effectively reduces PMN IL-8 production and chemotaxis.
- Statin therapy modulates the pro-inflammatory characteristics of PMNs in high-risk populations.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Bioavailability Study Design: Healthy Subjects Versus Patients